Does UBLITUXIMAB Cause Maternal exposure during pregnancy? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Maternal exposure during pregnancy have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 2.3% of all adverse event reports for UBLITUXIMAB.
36
Reports of Maternal exposure during pregnancy with UBLITUXIMAB
2.3%
of all UBLITUXIMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From UBLITUXIMAB?
Of the 36 reports.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBLITUXIMAB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Inappropriate schedule of product administration (53)
Malaise (49)
Multiple sclerosis relapse (48)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which UBLITUXIMAB Alternatives Have Lower Maternal exposure during pregnancy Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM